AS

Amber Salzman

CEO

Epicrispr Biotechnologies


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Epicrispr Biotechnologies
Industry
research
Employees
41.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
55000000.0
Latest Funding
Series A

Professional Summary

Amber Salzman serves as CEO at Epicrispr Biotechnologies. Epicrispr Biotechnologies operates in the research sector with approximately 41.0 employees. Epicrispr Biotechnologies generates annual revenue of 1000000.0. To date, Epicrispr Biotechnologies has raised 55000000.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • Our database includes 201,469 c suite-level executives.

Technologies

Gmail Google Apps Microsoft Office 365 Greenhouse.io Google Cloud Hosting Google Tag Manager Gravity Forms WordPress.org MailChimp Nginx reCAPTCHA Vimeo Mobile Friendly Remote

Keywords

biotechnology research epigenetic therapy genetic medicine gene modulation customized therapies gene expression epigenome editing crispr technology gene expression modulation system gems platform gene silencing dna-binding proteins guide rnas modulator proteins transcriptional activators transcriptional repressors epigenomic modulators mutation-agnostic therapeutic targets in vivo delivery ex vivo delivery neuromuscular diseases d4z4 methylation facioscapulohumeral muscular dystrophy clinical trials fda clearance biotechnology crispr-cas9 epigenetic editing gene therapy gene regulation molecular biology synthetic biology transcription factors chromatin remodeling gene therapy for rare diseases dcas9 pathogenics precision medicine genome engineering epigenetic biomarkers novel therapies biotherapeutics nuclease-deactivated cas9 therapeutic pipeline next-generation car-t cells protein engineering data science in biotech computational genomics genomic therapies bioengineering advancements health care health wellness & fitness hospital & health care

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Amber Salzman?

Amber Salzman's verified email address is available on MessageCEO. They currently work at Epicrispr Biotechnologies. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Amber Salzman lead?

Amber Salzman is CEO at Epicrispr Biotechnologies, a company in the research sector with 41.0 employees.

What industry is Amber Salzman in?

Amber Salzman works in the research industry as CEO at Epicrispr Biotechnologies. MessageCEO provides verified contact information for executives across all major industries.

Is Amber Salzman's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Amber Salzman's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 7, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans